CONTACT & CAREER
Use tab to navigate through the menu items.
News & Career
14 December 2021
We are delighted to announce the closing of our US$19.2M Pre-A Round, which we will use to accelerate nucleic acid therapeutics through innovative chemistry and biology to improve lives worldwide.
Cargene Closes a US$19.2M Pre-A Round Led by BioTrack Capital